eDiagnosis: Plans to repurchase company shares for 100 million to 200 million yuan
eDiagnosis announced plans to repurchase company shares for between 100 million and 200 million yuan, with a repurchase price not exceeding 28 yuan per share
eDiagnosis announced plans to repurchase company shares for between 100 million and 200 million yuan, with a repurchase price not exceeding 28 yuan per share
The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.
